Small cell lung cancer (SCLC)

A platform to prospectively link real-world clinico-genomic, imaging, and outcomes data for patients with lung cancer →

Walia, G, Lu, MW, Bourla, AB, Santos, EC, Schulze, K, Cabili, MN, Williams, EH, Mirkovich, N, DiCecca, RH, Lee, SE, Fang, B, Schwartzberg, L, Herbst, RS, Chiang, AC

January 2021

Abstract

World Conference on Lung Cancer

Flatiron-authored

Clinical and genomic characteristics of small-cell lung cancer in never-smokers →

Thomas, A, Mian, I, Tlemsani, C, Pongor, L, Takahashi, N, Maignan, K, Snider, J, Li, G, Frampton, GM, Ali, SM, Kim, S, Nichols, S, Rajapakse, V, Guha, U, Sharon, E, Fujimoto, J, Moran, CA, Witstuba, II, Wei, JS, Szabo, E, Torres, AZ, Carson, KR

May 2020

Manuscript

Chest

Flatiron-authored

Pan-cancer profiling of the effect of biopsied site on tumor mutational burden measurements in a real-world data cohort →

Papillon-Cavanagh, S, Gao, C, Han, GC, Walsh, AM

May 2020

Abstract

AACR Annual Meeting

A multi-stakeholder platform to prospectively link longitudinal real-world clinico-genomic, imaging, and outcomes data for patients with metastatic lung cancer →

Lu, MW, Walia, G, Schulze, K, Doral, MY, Maund, SL, Gaffey, S, Cabili, MN, Bourla, AB, Green, RJ, Santos, EC, Herbst, RS, Chiang, AC, Schwartzberg, L

May 2020

Abstract

ASCO Annual Meeting

Flatiron-authored

Use of prophylactic cranial irradiation in patients with extensive-stage small cell lung cancer receiving immunotherapy →

Yang, DX, Jairam, V, Park, HS, Decker, RH, Chiang, AC, Gross, CP, Yu, JB

May 2020

Abstract

ASCO Annual Meeting

Methodological approaches for incorporating real-world data (RWD) for overall survival (OS) into long-term survival estimates: a case-study nice technology appraisal in extensive-stage small-cell lung cancer (ES-SCLC) →

Connor, S, Orfanos, P, Flahavan, EM, Patterson, K, Lee, D

November 2019

Abstract

EU ISPOR

A landmark response analysis to determine cost-effectiveness of third-line nivolumab for small cell lung cancer →

Smare, C, Dave, K, Juarez-Garcia, A, Schoenherr, N, Abraham, P, Penrod, JR, Camidge, DR, Yuan, Y

November 2019

Abstract

EU ISPOR

A partitioned survival model to determine cost-effectiveness of third-line nivolumab monotherapy for small cell lung cancer →

Smare, C, Dave, K, Juarez-Garcia, A, Schoenherr, N, Abraham, P, Penrod, JR, Camidge, DR, Yuan, Y

November 2019

Abstract

EU ISPOR

New treatment option for ES-SCLC: Patient characteristics and use of an atezolizumab regimen in the real-world setting →

McCune, S, Ton, TGN, Whipple, S, Induru, RR, Horn, L, Percent, IJ, Mekhail, T, Goldschmidt, Jr., J, Leal, TA, MacVicar, GR, Braiteh, F, Daniel, DB, Hussein, M, Mansfield, AS, Lam, S, Johnson, A, Morris, S, Spira, A

September 2019

Abstract

World Conference on Lung Cancer